Jacobs Jeffrey W 4
4 · ARDELYX, INC. · Filed May 21, 2021
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Jacobs Jeffrey W
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1]2021-05-20$7.09/sh−721$5,110→ 124,051 total
Footnotes (1)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs|2021-05-21